NCT06674031 Knowledge of Cardiovascular Risk Factors in Chronic Kidney Disease Patients
| NCT ID | NCT06674031 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hacettepe University |
| Condition | Chronic Kidney Disease(CKD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 28 participants |
| Start Date | 2024-11-06 |
| Primary Completion | 2025-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 28 participants in total. It began in 2024-11-06 with a primary completion date of 2025-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to assess knowledge of cardiovascular risk factors, physical activity levels, health literacy and perceptions of benefits and barriers to exercise in patients with chronic kidney disease and compare them with healthy people.
Eligibility Criteria
Inclusion Criteria: * Patients with chronic kidney disease * Being aged 18-65 * Voluntary participation in the study Exclusion Criteria: * Having cognitive problems * Being illiterate
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06674031 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Chronic Kidney Disease(CKD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06674031 currently recruiting?
Yes, NCT06674031 is actively recruiting participants. Contact the research team at mervefirat@ahievran.edu.tr for enrollment information.
Where is the NCT06674031 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT06674031 clinical trial?
NCT06674031 is sponsored by Hacettepe University. The trial plans to enroll 28 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.